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Abstract   1 
Feasibility studies are needed to demonstrate that safe and effective manipulation of bowel 2 
during Minimal Access Surgery (MAS) can be obtained by use of magnetic force. This paper 3 
characterises two classes of magnetic particles: stainless steel microparticles (SS-µPs) and 4 
iron oxide nanoparticles (IO-nPs) in terms of their magnetisation, chemical composition, 5 
crystallinity, morphology and size distribution. Both magnetic particles were dispersed in a 6 
high viscosity biological liquid for intraluminal injection of bowel. Ex-vivo porcine bowel 7 
segments were then retracted by permanent magnetic probes of 5.0 and 10 mm diameter. 8 
Strong retraction forces reaching 6 N maximum were obtained by magnetic fluid based on 9 
dispersion of SS-µPs. In contrast, the IO-nP-based magnetic liquid generated less attraction 10 
force, due to both lower magnetic and solution properties of the IO-nPs. The comparison of 11 
the two particles allowed the identification of the rules to engineer the next generation of 12 
particles. The results with SS-µPs provide proof on concept that intraluminal injection of 13 
magnetic fluid can generate sufficient force for efficient bowel retraction. Thereafter we shall 14 
carry out in-vivo animal studies for efficacy and safety of both types of ferrofluids.  15 
 16 
Keywords (3-10)      Characterisation, magnetic particles, physical properties, magnetic 17 
bowel retraction, minimal access surgery (MAS) 18 
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1. Introduction 1 
Retraction of bowel during minimal access surgery (MAS) remains problematic as the 2 
moist low friction serosal surface is difficult to grasp with laparoscopic graspers. One study 3 
documented the low percentage (62 %) of successful grasping actions and indicated the need 4 
for improvement in laparoscopic grasper design [1].  5 
We have been investigating tissue magnetization by magnetic nano- and micro-particles 6 
for MAS applications and have previously reported two tissue ferromagnetisation approaches 7 
for tissue retraction: i) surface magnetization by applying a small volume of glue-based 8 
magnetic media to the mucosal/ serosal surface [2], and ii) by interstitial injection  of 9 
phosphate-buffered saline (PBS) ferrofluids [3]. In these experiments injected 10 
ferromagnetisation was shown to be superior to surface magnetisation by surface magnetic 11 
pellets, as the latter tended to peel off the tissue during retraction by magnetic probes. 12 
However, the restricted sub-mucosal space limited our injected media volume thus retraction 13 
force in previous interstitial injection method. 14 
In the present study, we report a novel method of magnetisation of a bowel segment by 15 
intra-luminal injection of magnetic ferrofluids using a custom-designed intra-abdominal 16 
suction-injection probe. We compare the behaviour of stainless steel microparticles (SS-µPs) 17 
and iron oxide nanoparticles (IO-nPs). The latter family of nPs was chosen due to their well-18 
established clinical use for applications including MRI contrast agents [4-8]. Detailed 19 
characterisation of magnetic particles used for making the magnetic ferrofluids for 20 
intraluminal bowel magnetisation and the retraction forces obtained in ex-vivo experiments 21 
using porcine bowel segments are reported and the comparison of four micro- and nano-22 
particles allowed the identification of the rules to engineer the next generation of particles.  23 
 24 
2. Materials and methods 25 
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2.1.  Magnetic particles  1 
Stainless steel microparticles and iron oxide nanoparticles were used as model magnetic 2 
particles. Two types of stainless steel microparticles (SS-µPs) were investigated:  stainless 3 
steel type 410 microparticles (SS410-µPs, from Goodfellow) and stainless steel type 430 4 
microparticles (SS430-µPs, from Alfa). Iron oxide nanoparticles were made in-house by 5 
forced hydrolysis (IOiH-nPs) and compared with commercial iron oxide powder (IOAlfa-nPs, 6 
from Alfa).  These types of materials were previously used in reported studies on 7 
medical/surgical applications [9-11].  8 
Preparation of in-house IOiH-nPs: aqueous FeCl3 and FeCl2 solutions were prepared 9 
separately in degassed DI-H2O (Milipore). The reaction environment was conditioned with a 10 
continuous and sustained flow of nitrogen and with a mechanical stirrer. Co-precipitation of 11 
the iron ions was completed at room temperature and by dropwise injection of a NH4OH 12 
solution at a rate of 60 mL/h. The iron oxide formed a black precipitate, which was collected 13 
at the bottom of the container and washed with degassed DI-H2O several times to remove 14 
free amine. The NH3-free nanoparticles were then dried in vacuum before use.  15 
All chemical reagents, unless otherwise stated, were purchased from Sigma, used without 16 
further purification and degassed before use only if specified: Iron(III) chloride (FeCl3, 17 
reagent grade >97 %), Iron(II) chloride tetrahydrate (FeCl2.4H2O, puriss. p.a. ≥ 99.0 %), 18 
ammonium hydroxide aqueous solution (NH4OH, 28-30 %).  19 
 20 
2.2.  Characterisation of magnetic particles 21 
The properties of the four types of particles were characterised with the following 22 
experimental techniques.  23 
SQUID: A 5.0 Tesla Superconducting Quantum Interference Device (SQUID) 24 
magnetometer from Quantum Design (MPMS XL
TM
) was used to quantify the particles 25 
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magnetic properties. They were dispersed in a polymeric matrix to prevent interaction 1 
between nearby particles. The resulting sample was loaded into a low magnetic background 2 
gelatin capsule. Hysteresis measurements were completed at 300 K. The magnetization of the 3 
gelatine capsules and the polymeric matrix was subsequently subtracted. 4 
XRD: Wide-angle powder X-ray diffraction (XRD) was used to assess the particle 5 
crystallinity and grain size. The data were collected on a Stoe STADI/P powder 6 
diffractometer operating in transmission mode and with a small angle position sensitive 7 
detector. Incident radiation was generated using a FeKα1 source (λ=1.936 Å). The strongest 8 
peak was fitted with Lorentzian-shaped peaks using STOEwinXpow and KaleidaGraph 9 
software packages to determine the diffraction peak positions and widths. The crystalline 10 
grain size, DXRD, of the particles was calculated according to Scherrer’s formula[12]:  11 


cos
9.0
B
XRDD            (1) 12 
where DXRD is the “average” dimension of the crystallites, λ is the wavelength of the X-ray 13 
source (for Fe source is equal to 0.193604 nm), B is the full width at half maximum of the 14 
peak intensity, θ is the glancing angle.  15 
Electron microscopy: Their sizes and morphology determined by electron microscopy 16 
(Transmission (TEM) and Scanning (SEM) electron microscope). TEM images were 17 
recorded using a Gatan CCD camera on a JEOL JEM-2011 microscope operating at 200 kV. 18 
SEM images were recorded using a Hitachi S-4800 microscope. 19 
ICP-OES:  The chemical composition of all particles was analysed by Inductively 20 
Coupled Plasma Optical Emission Spectrometry (ICP-OES). A Perkin Elmer Optima 5300 21 
DV was used as Inductively Coupled Plasma Optical Emission Spectrometer. The particles 22 
were mixed with hydrochloric acid (Trace SELECT®, ≥37 %) and nitric acid (Trace 23 
SELECT®, ≥69.0 %) in a 3:1 acid volume ratio and left overnight at room temperature. After 24 
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full dissolution of the particles, the solution was diluted with deionised water to prepare 1 
inductively coupled plasma-atomic emission spectrometry measurements. 2 
 3 
2.3.  Preparation of magnetic ferrofluids for intra-luminal bowel injection 4 
Magnetic particles were dispersed in phosphate buffered saline (PBS) together with high 5 
viscosity fluids such as glycerol (80 % v/v) in order to improve their suspension and 6 
dispersion [3]. Concentrations of magnetic particles ranging from 0.1 to 1 g/mL were used for 7 
the magnetic bowel retraction studies. In a typical preparation protocol, for one ferrofluid 8 
formulation containing 0.25 g/mL fluid, 1.0 g of magnetic particles were added into a 9 
Sure/SealTM bottle which already contained 4 mL glycerol/PBS (80 % v/v) fluid.  The 10 
magnetic particles were suspended in the liquid by vigorous hand and mechanical shaking of 11 
the sealed bottle prior to using the ferrofluid for intraluminal bowel injection.  12 
A 10 mm diameter intra-abdominal suction-injection probe was designed and made-in-13 
house. The probe applies initial suction through small suction holes at its distal end before its 14 
long needle (19-gauge) is inserted, via a central channel of the probe, into the lumen of the 15 
bowel for injection of ferrofluid in large volume. More detailed illustration of our proposed 16 
transperitoneal injection can be found from our recently published glue-based magnetic fluid 17 
for bowel magnetisation and retraction [13]. This design facilitates intraluminal injection 18 
without the need for use of additional graspers.  19 
Harvested porcine colons were injected with the ferrofluids, after which the injection 20 
device was removed and the magnet probe was brought into contact with the bowel at the 21 
injection site. In these experiments, the magnetic attraction force was measured using a 22 
tensiometer [2] (Model 5564, Instron Ltd, Buckinghamshire, UK). The magnetic probe was 23 
made from neodymium iron boron (NdFeB) disc magnets with a remanence of 1.20 T (grade 24 
N35, Eclipse Magnetics Ltd, Sheffield, UK), and diameters of both 5 mm and 10 mm (30 mm 25 
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in length). The magnetic field at the surface of the magnets was measured with a 1 
magnetometer (Model #DCM 2320, AlphaLab, Inc., Salt Lake City, UT) and found to be 2 
equal to 0.46 T and 0.53 T for the 5mm and 10mm probes, respectively.   3 
 4 
3.  Results 5 
3.1.  Characterisation of magnetic particles 6 
Four types of magnetic particles were investigated, Table 1 lists the physical properties as 7 
obtained by SEM and XRD, SQUID at 300 K, and ICP-OES.  8 
 9 
Table 1 10 
Characterization of the magnetic particles: size as obtained by SEM and XRD characterizations, 11 
magnetization at saturation (Ms) and coercivity (Hc) measured with a SQUID magnetometer at 300 K, 12 
Iron and chromium percentage as deduced from ICP-OES measurements, average maximum of the 13 
magnetic retraction forces Fmax of a magnetised bowel segments in 20 ex-vivo experiments using the 10 14 
mm magnet probe (injected magnetic media at concentration 0.25 g/mL: intraluminally injected 4 mL). 15 
Normalised retractions forces with the surface of the magnet and the magnetization at saturation.  16 
 SS410-µPs SS430-µPs IOiH-nPs  IOAlfa-nPs  
Size (diameter) up to 50 µm
 SEM
 up to 40 µm 
SEM
 ~ 13 nm 
XRD
 ~ 25 nm 
XRD
 
Ms (emu/g) 168.0 110.0 11.0 2.0 
Hc (kOe) 0.01 0.02 0.25 0.06 
Fe (w %) 
Cr (w %) 
86.6 ± 6.8 
12.6 ± 1.0 
82.2 ± 6.7 
16.9 ± 1.4 
na na 
Fmax (N) 5.9 ± 1.0 5.8 ± 0.6 1.3 ± 0.4 2.0 ± 0.1 
σ (kPa) 75.67 ± 12.5 74.0 ± 7.0 16.69 ± 4.3 24.97 ± 1.4 
Fmax/Ms (Ng/emu) 0.035 ± 0.006 0.053 ± 0.005 0.12 ± 0.03 0.98 ± 0.10 
 17 
Fig. 1a presents the morphology as observed by electron microscopy for iron oxide 18 
nanoparticles. XRD patterns, Fig. 1b, are characteristic of Fe3O4 and were used to extract the 19 
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crystalline grain size. Magnetic properties were quantified at room temperature in terms of 1 
magnetization as function of applied magnetic field and the resulting curves are presented in 2 
Fig. 1c. The morphologies and magnetisation curves for the commercial stainless steel 3 
microparticles were reported earlier elsewhere [13]. As expected, the curves are symmetric 4 
and the magnetization at saturation, Ms, can be deduced from the plateau, when the 5 
magnetization does not increase any more with the magnetic field.   6 
 7 
 8 
Fig. 1:  For IOiH-nPs (1) and IOAlfa-nPs (2): Scanning Electron Microscopy images (a), XRD spectra of the 9 
Fe3O4 nPs (b) and hysteresis curves completed at room temperature (c). Insets present TEM images of IO-nPS 10 
with a 20 nm scale bar (a) and zoomed magnetisation response for low magnetic fields (c). 11 
 12 
The magnetization curves of both µPs fell to zero magnetisation when the magnetic field 13 
equalled zero, indicating that there was no significant coercivity (Hc) and no observable 14 
remanence (Table 1). The coercivity refers to the magnetic field which needs to be applied to 15 
reduce the magnetization of a material down to zero after the magnetization of the sample has 16 
been driven to saturation. This implies that SS-µPs even though too large to form stable 17 
solution would not face further difficulty in dispersion  in the fluid due to magnetic 18 
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interactions since the particles experience no mutual magnetic attraction until placed in a 1 
magnetic field. In contrast, the smaller size nPs would face magnetic interactions at room 2 
temperature so that a degree aggregation/ clumping occurs, as observed on the SEM and 3 
TEM images in Fig. 1ab. 4 
 5 
3.2  Ferrofluid injection and bowel retraction by magnet probe 6 
Table 1 also summarises the magnetic retraction forces of a magnetised bowel segments in 7 
20 ex-vivo experiments using the 10 mm magnet probes with a 4 mL ferrofluid injection (Fig. 8 
2a-b), that is, the number of measurements per type of ferrofluid and probe size was 20 with 9 
standard deviations shown in Table 1 and Fig. 2c. Ferrofluids based on both SS-MPs could 10 
generate maximal force near 6 N while IO-nPs-based media could only provide about 1 to 2 11 
N retraction force.  12 
In our previous study [3], we observed that magnetic attraction force increased 13 
proportionally with the injected volume of a solution of constant particle concentration. 14 
However, the maximal possible injected volume for interstitial (sub-mucosal) injection is 15 
limited to 0.2 mL and this limits the retraction force possible with this form of tissue 16 
magnetisation. This problem is avoided with intraluminal injection into the bowel lumen. 17 
Although one can inject as many fluids as possible into the bowel lumen, a practical threshold 18 
could be estimated. For example, as shown in Fig. 2c, there was no or just minor increase in 19 
its magnetic retraction force beyond 4 mL injection. Specifically, magnet probes with 10 mm 20 
and 5 mm diameters were used. With 10 mm probe, magnetic retraction force increased with 21 
increase of injected magnetic volume of ferrofluid and particle content/mass from 0.25 g (1 22 
mL) up to 1 g (4 mL). There was almost no retraction force increase beyond 1 g of injected 23 
particles, indicative of saturation at this mass/content. The smaller magnet (5 mm) required 24 
even less particles to reach its saturation force. As magnetic attraction force between the 25 
magnet probe and injected particle decreases exponentially with their distance, any further 26 
10 
 
 
 
injection of magnetic ferrofluid simply pushes the magnetic particles further away from the 1 
magnet and thus contributes significantly less to the attraction force.  2 
 3 
Fig. 2:  Ex-vivo porcine bowel retraction and force measurement: (a) Photograph of a magnetised bowel 4 
segment retracted during Instron force measurement. (b) Extension-load curve demonstrating a maximum force 5 
before slipping occurs (normalised to unity for illustration purpose). (c) Injection volume versus magnetic 6 
retraction force using two-sized magnet probes.  7 
 8 
4.  Discussion 9 
The suction-injection probe first tented the target bowel segment and generated large 10 
lumen space in order to facilitate intraluminal injection of ferrofluid into lumen. This avoids 11 
fluid to be injected into sub-mucosa or through the bowel into abdominal space. The injected 12 
fluid was temporarily maintained in the intended lumen section of the intestine due to its high 13 
viscosity (i.e., glycerol suspension), and the magnet probe was then located at the injection 14 
section immediately after withdrawal of the injection probe. Although a very small volume of 15 
fluid, e.g. 4 mL, is needed to interact with the magnet probe for generating sufficient force, in 16 
practical a larger volume (e.g. >10 mL) could be readily injected into the intended lumen 17 
section. Although the fluid would disperse throughout the lumen, in our ex-vivo experimental 18 
setup, we found there was always sufficient ferrofluid remaining to interact with the magnet 19 
probe.   20 
 21 
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The average pull force that surgeons use to provide enough tension to the bowel is known 1 
to be 2.5 N while the maximal force is just below 5 N.[14]  The test results presented in Table 2 
1 and Fig. 2 indicate that SS-µPs based bowel magnetization would be capable of providing 3 
sufficient retraction force for bowel manipulation. The pressure generated between the 4 
magnetic fluid and the probe was up to 76 kPa in the present study which would cause less 5 
trauma to the target tissue. For example, the pressure generated from this device is 6 
significantly lower than that generated by forceps or graspers (210 to 650 kPa [15]), also used 7 
for laparoscopic bowel retraction. Much higher trans-mural pressures were used in order to 8 
cause tissue ischemia in compressive magnetic anastomosis, for example in gastrointestinal 9 
(600 kPa) and bilioenteric (1 MPa) anastomosis [16]. In our application, the probe is removed 10 
once the operation is completed, thus the fluid is eliminated in the stools after surgery. A 11 
retractable permanent magnet housed inside the probe distal segment could provide an 12 
adjustable magnetic attraction force for safe tissue manipulations.  For example, in one 13 
custom-design, an 8 mm-diameter and 20 mm-long magnet housed within a 10 mm tubular 14 
probe produced a maximal retraction force of 3.5 N when the probe was in contact with the 15 
magnetised bowel. The force could be reduced to 0.3 N by controlled movement of the 16 
magnet, thereby enabling controlled release of the magnetised target bowel. Details about this 17 
custom-design magnet probe will be published elsewhere.   18 
 19 
5.  Conclusion 20 
The physical properties of magnetic particles were investigated and the relative 21 
performances were compared. Injectable high viscosity magnetic ferrofluids were developed 22 
for magnetic bowel retraction and were characterised in an ex-vivo porcine bowel model. The 23 
present approach utilizes the magnetic interactions to retract internally magnetised bowels 24 
towards an external (intra-abdominal) magnetic probe for safe and effective bowel 25 
12 
 
 
 
manipulations. The results of the current experiments indicate that with the technology 1 
described, stainless steel micro-particles provide sufficient magnetic attraction force for 2 
bowel manipulation. With at least one order of magnitude smaller magnetisation at saturation, 3 
IO-nPs fell short by only 20 % to provide of sufficient magnetic attraction force. On-going 4 
research is in progress to address the identified challenges and ideal nPs would be engineered 5 
to be either super-paramagnetic or coated with a layer providing both solubility and repulsive 6 
interactions between the nanoparticles to improve the dispersion in the selected solvent, 7 
collection from the jar, and injection into the bowel. To engineer the next generation of 8 
particles, these are more important parameters than the magnetisation at saturation of a 9 
specific magnetic material. With this in mind, the library of magnetic particles suitable to 10 
retract internally magnetised bowels towards an external (intra-abdominal) magnetic probe 11 
for safe and effective bowel manipulations should drastically expand. Finally, in-vivo animal 12 
studies should next be completed to insure efficacy and safety of ferrofluids. 13 
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